Adrian F. Hernandez
Duke University
1021 Papers
3.7K Citations
Adrian F. Hernandez is an academic researcher from Duke University. The author has contributed to research in topics: Medicine & Heart failure. The author has an hindex of 100, co-authored 849 publications. Previous affiliations of Adrian F. Hernandez include University of Mississippi Medical Center & Cleveland Clinic.
Chat about Author
Papers
Outcomes of medicare beneficiaries with heart failure and atrial fibrillation
Prateeti Khazanie,Prateeti Khazanie,Li Liang,Li Liang,Laura G. Qualls,Laura G. Qualls,Lesley H. Curtis,Lesley H. Curtis,Gregg C. Fonarow,Gregg C. Fonarow,Bradley G. Hammill,Bradley G. Hammill,Stephen C. Hammill,Stephen C. Hammill,Paul A. Heidenreich,Paul A. Heidenreich,Frederick A. Masoudi,Frederick A. Masoudi,Adrian F. Hernandez,Adrian F. Hernandez,Jonathan P. Piccini,Jonathan P. Piccini +21 more
TL;DR: This paper analyzed 27,829 atrial fibrillation admissions from 2006-2008 at 281 hospitals participating in the American Heart Association's Get With (Get With) program. But the associations of preexisting and new-onset AF with long-term outcomes are unclear.
8
Variation in use and dosing escalation of renin angiotensin system, mineralocorticoid receptor antagonist, angiotensin receptor neprilysin inhibitor and beta-blocker therapies in heart failure and reduced ejection fraction: Association of comorbidities
Nancy M. Albert,Rachel J. Tyson,C. Larry Hill,Adam D. DeVore,John A. Spertus,Carol I. Duffy,Javed Butler,J. Herbert Patterson,Adrian F. Hernandez,Fredonia B. Williams,Laine Thomas,Gregg C. Fonarow +11 more
TL;DR: In this paper, the authors used multivariate hierarchical logistic models to assess the association between ACEi/ARB/ARNI, MRA and βB medication use and dose by comorbidities after adjusting for patient characteristics.
8
Are existing and emerging biomarkers associated with cardiorespiratory fitness in patients with chronic heart failure
Marat Fudim,Marat Fudim,Jacob P. Kelly,Aaron D. Jones,Omar F. AbouEzzeddine,Andrew P. Ambrosy,Stephen J. Greene,Yogesh N.V. Reddy,Kevin J. Anstrom,Brooke Alhanti,Gregory D. Lewis,Adrian F. Hernandez,G. Michael Felker +12 more
TL;DR: Novel biomarkers do not appear suitable as a reliable surrogate for serial assessment of exercise capacity in HF patients given lack of consistent independent association with CRF beyond traditional risk factors and NT-proBNP.
8
Heart Failure Clinical Trial Operations During the COVID-19 Pandemic: Results From a Multicenter Survey.
Marc D. Samsky,Adam D. DeVore,Colleen K. McIlvennan,Christopher B. Granger,Bradi B. Granger,Bradi B. Granger,Adrian F. Hernandez,G. Michael Felker,Gregg C. Fonarow,Nancy M. Albert,Ileana L. Piña,David E Lanfear,Larry A. Allen +12 more
8